Stochastic Modeling and Simulation of the p53-MDM2/MDMX Loop

The p53 gene is crucial for effective tumor suppression in humans as supported by its universal inactivation in cancer cells either through mutations affecting the p53 locus directly or through aberration of its normal regulation. The p53 tumor repressor is regulated through a negative feedback loop involving its transcriptional target MDM2. MDMX is also an essential negative regulator of p53. Several computational models have been proposed to simulate the dynamics of the p53-MDM2 loop, but they do not include MDMX, only account for some basic interactions between p53 and MDM2 and cannot capture the intrinsic noise in the loop. In this article, we present a comprehensive model for the p53-MDM2/MDMX loop that accounts for most known interactions among p53, MDM2 and MDMX. Our model is characterized by a set of molecular reactions, which enables us to employ stochastic simulation to investigate the dynamics of the loop. In agreement with experiments, our results show that p53 and MDM2 undergo oscillations after DNA damage in the presence of noise, and the variation in oscillation amplitudes is much higher than that in oscillation periods. Our simulations predict that intrinsic noise contributes to 60%-70% of the total variation in oscillation amplitudes and periods. The protein levels of p53, MDM2, and MDMX after treatment with Nutlin in our simulations are also consistent with experimental results. Our simulation results further predict that p53 levels increase dramatically after MDM2 is knocked out, but increase with a much less amount after MDMX is knocked out. This may partially explain why MDM2-null and MDMX-null mouse embryos die in different developmental stages. Our stochastic model and simulation provide insights into the variability of the behavior of the p53 pathway and can be used to predict the dynamics of the pathway after certain interventions.

[1]  T. Tursz,et al.  Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells , 1998, Oncogene.

[2]  A. Jochemsen,et al.  Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53* , 2002, The Journal of Biological Chemistry.

[3]  John Jeremy Rice,et al.  A plausible model for the digital response of p53 to DNA damage. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  John D. Storey,et al.  Genome-wide analysis of mRNA translation profiles in Saccharomyces cerevisiae , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Hong Yang,et al.  Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis*♦ , 2004, Journal of Biological Chemistry.

[6]  K. Sakaguchi,et al.  Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like Kinase , 2000, The Journal of Biological Chemistry.

[7]  A. Levine,et al.  The P53 pathway: what questions remain to be explored? , 2006, Cell Death and Differentiation.

[8]  J. Landers,et al.  Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. , 1997, Cancer research.

[9]  G. Wahl,et al.  Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX , 2007 .

[10]  G. Mize,et al.  Role of two upstream open reading frames in the translational control of oncogene mdm2 , 1999, Oncogene.

[11]  Jeremy R Stuart,et al.  DNA Damage-induced MDMX Degradation Is Mediated by MDM2* , 2003, Journal of Biological Chemistry.

[12]  D. Gillespie Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .

[13]  M. Oren,et al.  A functional p53-responsive intronic promoter is contained within the human mdm2 gene. , 1995, Nucleic acids research.

[14]  A. Fersht,et al.  Molecular mechanism of the interaction between MDM2 and p53. , 2002, Journal of molecular biology.

[15]  M. Oren,et al.  Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. , 1994, Genes & development.

[16]  M. E. Perry,et al.  Characterization of the 5' and 3' untranslated regions in murine mdm2 mRNAs. , 2001, Gene.

[17]  Guillermina Lozano,et al.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.

[18]  K. McLure,et al.  How p53 binds DNA as a tetramer , 1998, The EMBO journal.

[19]  J. Raser,et al.  Noise in Gene Expression: Origins, Consequences, and Control , 2005, Science.

[20]  D. Faller,et al.  DNA-damaging Aryl Hydrocarbons Induce Mdm2 Expression via p53-independent Post-transcriptional Mechanisms* , 2000, The Journal of Biological Chemistry.

[21]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[22]  G. Wahl,et al.  Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation , 2004, The EMBO journal.

[23]  Yu Pan,et al.  MDM2 Promotes Ubiquitination and Degradation of MDMX , 2003, Molecular and Cellular Biology.

[24]  R. Ramirez-Solis,et al.  mdmx is a negative regulator of p53 activity in vivo. , 2002, Cancer research.

[25]  N. Little,et al.  Hdmx stabilizes Mdm2 and p53. , 2000, The Journal of biological chemistry.

[26]  G. Stark,et al.  Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3. , 2006, Cancer research.

[27]  A. Arkin,et al.  Stochastic mechanisms in gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Levine,et al.  Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. , 1993, Oncogene.

[29]  R. Copeland,et al.  Thermodynamics of p53 binding to hdm2(1-126): effects of phosphorylation and p53 peptide length. , 2000, Archives of biochemistry and biophysics.

[30]  K. Sneppen,et al.  Time delay as a key to apoptosis induction in the p53 network , 2002, cond-mat/0207236.

[31]  Muyang Li,et al.  A dynamic role of HAUSP in the p53-Mdm2 pathway. , 2004, Molecular cell.

[32]  M. Oren Regulation of the p53 Tumor Suppressor Protein* , 1999, The Journal of Biological Chemistry.

[33]  R. Milo,et al.  Oscillations and variability in the p53 system , 2006, Molecular systems biology.

[34]  Ruedi Aebersold,et al.  Gene expression in yeast responding to mating pheromone: Analysis by high-resolution translation state analysis and quantitative proteomics , 2004 .

[35]  J C Hewson,et al.  Stochastic simulation of transport and chemical kinetics in turbulent CO/H2/N2 flames , 2001 .

[36]  Jean-Christophe Marine,et al.  Mdmx as an essential regulator of p53 activity. , 2005, Biochemical and biophysical research communications.

[37]  G. Wahl,et al.  Quantitative analyses reveal the importance of regulated Hdmx degradation for P53 activation , 2007, Proceedings of the National Academy of Sciences.

[38]  J. Gregg,et al.  Allele-specific Holliday junction formation: a new mechanism of allelic discrimination for SNP scoring. , 2003, Genome research.

[39]  A. Jochemsen,et al.  MDMX: a novel p53‐binding protein with some functional properties of MDM2. , 1996, The EMBO journal.

[40]  Muyang Li,et al.  Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2 , 2003, Science.

[41]  A. Levine,et al.  The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.

[42]  K. Shirouzu,et al.  MDM2 interacts with MDMX through their RING finger domains , 1999, FEBS letters.

[43]  K. Vousden,et al.  Coping with stress: multiple ways to activate p53 , 2007, Oncogene.

[44]  Hyunggee Kim,et al.  Post-transcriptional inactivation of p53 in immortalized murine embryo fibroblast cells , 2001, Oncogene.

[45]  K. Helin,et al.  Mdm4 (Mdmx) Regulates p53-Induced Growth Arrest and Neuronal Cell Death during Early Embryonic Mouse Development , 2002, Molecular and Cellular Biology.

[46]  Andrea Ciliberto,et al.  Steady States and Oscillations in the p53/Mdm2 Network , 2005, Cell cycle.

[47]  H. Xiao,et al.  Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. , 2000, Carcinogenesis.

[48]  H. Dolznig,et al.  Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments. , 2007, RNA.

[49]  N. Sonenberg,et al.  1 Origins and Principles of Translational Control , 2007 .

[50]  T Misteli,et al.  Functional architecture in the cell nucleus. , 2001, The Biochemical journal.

[51]  A. Levine,et al.  Human TAFII31 protein is a transcriptional coactivator of the p53 protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Hyunggee Kim,et al.  The rapid destabilization of p53 mRNA in immortal chicken embryo fibroblast cells , 2001, Oncogene.

[53]  A. Levine,et al.  The mdm-2 gene is induced in response to UV light in a p53-dependent manner. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Tom Misteli,et al.  Functional architecture in the cell nucleus. , 2001 .

[55]  A. Levine,et al.  p53-Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback. , 2005, Systems biology.

[56]  Mengjia Tang,et al.  Hdmx Modulates the Outcome of P53 Activation in Human Tumor Cells* , 2006, Journal of Biological Chemistry.

[57]  W. Deppert,et al.  Cell-specific transcriptional activation of the mdm2-gene by ectopically expressed wild-type form of a temperature-sensitive mutant p53. , 1995, Oncogene.

[58]  C. Maki Oligomerization Is Required for p53 to be Efficiently Ubiquitinated by MDM2* , 1999, The Journal of Biological Chemistry.

[59]  Baoli Hu,et al.  MDMX Overexpression Prevents p53 Activation by the MDM2 Inhibitor Nutlin* , 2006, Journal of Biological Chemistry.

[60]  A. Gronenborn,et al.  High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. , 1994, Science.

[61]  M. E. Perry,et al.  The p53 Tumor Suppressor Protein Does Not Regulate Expression of Its Own Inhibitor, MDM2, Except under Conditions of Stress , 2000, Molecular and Cellular Biology.

[62]  H. Kawai,et al.  Mutual Dependence of MDM 2 and MDMX in Their Functional Inactivation of p 53 * , 2002 .

[63]  G. Wahl,et al.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas , 2006, Nature Reviews Cancer.

[64]  Patrick W. Lee,et al.  Biogenesis of p53 Involves Cotranslational Dimerization of Monomers and Posttranslational Dimerization of Dimers , 2002, The Journal of Biological Chemistry.

[65]  U Alon,et al.  Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  C. Arrowsmith,et al.  Solution structure of the tetrameric minimum transforming domain of p53 , 1995, Nature Structural Biology.

[67]  J. C. Schmitz,et al.  Regulation of p53 Expression in Response to 5-Fluorouracil in Human Cancer RKO Cells , 2007, Clinical Cancer Research.

[68]  Uri Alon,et al.  Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.

[69]  Jelena Kovacevic,et al.  Wavelets and Subband Coding , 2013, Prentice Hall Signal Processing Series.

[70]  Mihee M. Kim,et al.  RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity. , 2007, Cancer research.

[71]  A. Fersht,et al.  Cooperative binding of tetrameric p53 to DNA. , 2004, Journal of molecular biology.

[72]  A. Levine,et al.  Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.

[73]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[74]  A. Ciechanover,et al.  HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[75]  B. Vojtesek,et al.  Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. , 1999, The Biochemical journal.

[76]  A. Fersht,et al.  Comparative binding of p53 to its promoter and DNA recognition elements. , 2005, Journal of molecular biology.

[77]  Valerie Reinke,et al.  Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53 , 2001, Nature Genetics.

[78]  George I. Mihalas,et al.  POSSIBLE OSCILLATORY BEHAVIOR IN P53–MDM2 INTERACTION COMPUTER SIMULATION , 2000 .

[79]  S. Letteboer,et al.  Hdmx Protein Stability Is Regulated by the Ubiquitin Ligase Activity of Mdm2* , 2003, Journal of Biological Chemistry.

[80]  D. George,et al.  Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein* , 1999, The Journal of Biological Chemistry.

[81]  R. Aebersold,et al.  Gene Expression Analyzed by High-resolution State Array Analysis and Quantitative Proteomics , 2004, Molecular & Cellular Proteomics.

[82]  H. Ovaa,et al.  Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. , 2005, Molecular cell.

[83]  Xiaodong Cai,et al.  Exact stochastic simulation of coupled chemical reactions with delays. , 2007, The Journal of chemical physics.

[84]  R. Copeland,et al.  A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination. , 2006, Biochemistry.

[85]  P. Hainaut,et al.  25 years of p53 research , 2005 .

[86]  A. Telser Molecular Biology of the Cell, 4th Edition , 2002 .

[87]  G. Wahl,et al.  Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4 , 2006, Cell Death and Differentiation.

[88]  T. Elston,et al.  Stochasticity in gene expression: from theories to phenotypes , 2005, Nature Reviews Genetics.

[89]  M. Oren,et al.  Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. , 1993, Oncogene.

[90]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[91]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[92]  N. Monk Oscillatory Expression of Hes1, p53, and NF-κB Driven by Transcriptional Time Delays , 2003, Current Biology.

[93]  M. Kubbutat,et al.  Regulation of Mdm2-Directed Degradation by the C Terminus of p53 , 1998, Molecular and Cellular Biology.

[94]  Lawrence A. Donehower,et al.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.

[95]  M. Magnasco,et al.  Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes. , 2003, Genome research.

[96]  M. Gorospe,et al.  RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation , 2003, Proceedings of the National Academy of Sciences of the United States of America.